Skip to main content

Advertisement

SpringerLink
Log in

Drug discovery alliances

  • From the Analyst's Couch
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Preclinical discovery alliances.

References

  1. Booth, B. From the analyst's couch: valuation with cash multiples. Nature Rev. Drug Discov. 4, 533–534 (2005).

    Article  CAS  Google Scholar 

  2. Beyond Borders: Ernst & Young Global Biotechnology Report (Ernst & Young, London, 2005).

Download references

Author information

Authors and Affiliations

  1. Ernst & Young's Pharmaceutical Practice, UK

    Andrew Jones & Les Clifford

  2. Ernst & Young's Pharmaceutical Practice, 1 More London Place, London, SE1 2AF, UK

    Andrew Jones & Les Clifford

Authors
  1. Andrew Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Les Clifford
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jones, A., Clifford, L. Drug discovery alliances. Nat Rev Drug Discov 4, 807–808 (2005). https://doi.org/10.1038/nrd1856

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd1856

  • Springer Nature Limited

This article is cited by

Search

Navigation